Tissue Samples Clause Samples
The "Tissue Samples" clause governs the collection, use, and handling of biological tissue samples within the context of an agreement or research project. It typically outlines the procedures for obtaining consent from donors, specifies how samples will be stored, used, and possibly shared with third parties, and may address issues such as confidentiality and ownership. By clearly defining these terms, the clause ensures ethical compliance, protects the rights of sample donors, and clarifies responsibilities regarding the management of tissue samples.
Tissue Samples. Roche has certain tissue samples related to the subject matter of this Agreement (“Samples”). Upon the request of VIA, Roche shall provide VIA with access to these Samples or transfer such Samples to VIA. Once Roche’s right of first negotiation under Section 2.6 is exhausted, Roche shall have the right to transfer such Samples to VIA.
Tissue Samples. Strata Oncology shall use commercially reasonable efforts to obtain Tissue Samples for Participating Patients that will allow for Strata Oncology to perform the Strata Oncology Testing Services and retain a portion of the Tissue Sample for Clovis to use in accordance with this Section 3.4. If Strata Oncology has reserved a portion of the Tissue Sample following its testing and, at Clovis’ request, with respect to any such Tissue Sample, and to the extent consistent with Applicable Law, Strata Oncology shall provide Clovis with confirmation that all necessary approvals and informed consents have been obtained with respect to such Tissue Sample. Clovis shall be authorized to use such reserved Tissue Samples solely to conduct any additional testing that is contemplated by the clinical protocol for the Clovis Trials and authorized under Clovis’ patient informed consent for such Clovis Trials or the Patient ICF for the Strata Trial.
Tissue Samples. During the Term, Geisinger shall set aside for the exclusive use of Interleukin and not license to any Third Party, [***] sample(s) (at least 400 milligrams each) taken from [***] and [***] from fifty (50) patients that are represented in the 824 individuals whose DNA will be received under this Agreement for a total of fifty (50) sample sets, collected and banked from October 2004 through the Effective Date, and for which Interleukin may license from Geisinger (the “[***] Sample Option”). At any time during the Term, upon written notice to Geisinger, Interleukin may receive quantities of and a license to all of the [***] sample sets (“Full [***] Execution”) or some of the sample sets (“Partial [***] Execution”), with a minimum execution of ten (10) sample sets at a time. The cost of Geisinger providing the license and samples sets to Interleukin for the Partial [***] Execution or the Full [***] Execution is $[***] per sample set, payable within thirty (30) days of Interleukin’s receipt of written invoice from Geisinger. Promptly following ▇▇▇▇▇▇▇▇▇’▇ receipt of the above notice of exercise is given by and payment is received, Geisinger shall ship the selected number of set-aside [***] samples to Interleukin for its use, and Interleukin’s rights and restrictions on use of these [***] samples shall be governed by the same terms set forth in this Agreement applicable to the use of Samples. Starting six months after the Effective Date and prior to Full Execution of or termination of the [***] Sample Option, Interleukin shall pay Geisinger a quarterly maintenance fee of $[***] per calendar quarter, payable in cash no later than thirty (30) days after the end of every calendar quarter for which the [***] Sample Option remains active (the “Phase One [***] Sample Option Maintenance Fee”). If the [***] Sample Option remains active for one (1) year, the quarterly maintenance fee shall increase to $[***] per calendar quarter, payable in cash no later than thirty (30) days after the end of every calendar quarter for which the [***] Sample Option remains active (the “Phase Two [***] Sample Option Maintenance Fee”). For the first Partial [***] Execution or Full [***] Execution that occurs at least six (6) months after the Effective Date, Geisinger shall ▇▇▇▇▇ to Interleukin a one-time discount equal to the price of Partial [***] Execution or Full [***] Execution minus the amount of the current quarterly [***] Sample Option Maintenance Fee. (By way of examples: If the f...
Tissue Samples. Sample Preparation Analysis Method and Counting Rules